Estimating the cost of diabetes mellitus-related events from inpatient admissions in sweden using administrative hospitalization data

PharmacoEconomics

Volumn 27, Issue 1, 2009, Pages 81-90

  Gerdtham, Ulf G ^a,b   Clarke, Philip ^c   Hayes, Alison ^c   Gudbjornsdottir, Soffia ^d  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF SYDNEY   (Australia)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DIAGNOSIS RELATED GROUP; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE SYSTEM; HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; REGISTER; REGRESSION ANALYSIS; STATISTICAL MODEL; STROKE; SWEDEN;

ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; DIABETES MELLITUS; FEMALE; HOSPITAL COSTS; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SWEDEN;

EID: 59049100524     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200927010-00008     Document Type: Article

References (23)

1. American Diabetes Association Consensus Panel. Guidelines for computer modeling of diabetes and its complications. Diabetes Care 2004; 27: 2262-5
2. Norlund A, Apelqvist J, Bitzen PO, et al. Cost of illness of adult diabetes mellitus underestimated if comorbidity is not considered. J Intern Med 2001 Jul; 250 (1): 57-65
3. Brown JB, Pedula KL, Bakst AW. The progressive cost of complications in type 2 diabetes mellitus. Arch Int Med 1999; 159: 1873-80
4. Clarke PM, Gray A, Briggs A, et al., on behalf of the UK Prospective Diabetes Study (UKPDS 72). Cost utility analyses of intensive blood-glucose and tight blood-pressure control in type 2 diabetes. Diabetologia 2005 May; 48 (5): 868-77
5. Clarke PM, Gray AM, Briggs A, et al. A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 68) Outcomes Model. Diabetologia 2004; 47: 1747-59
6. Palmer AJ, Roze S, Valentine WJ, et al. The CORE diabetes model: projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (type 1 and 2) to support clinical and reimbursement decision-making. Cur Med Res 2004; 20: S5-26
7. Clarke P, Gray A, Legood R, et al. The impact of diabetes-related complications on health care costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65). Diabet Med 2003; 20: 442-50
8. O'Brien JA, Shomphe LA, Kavanagh PL, et al. Direct medical costs of complications from type 2 diabetes mellitus in the US. Diabetes Care 1998; 21: 1122-8
9. Clarke P, Kelman C, Colagiuri S. Factors influencing the cost of hospital care for people with diabetes in Australia. J Diabetes Complications 2006; 20 (6): 349-55
10. Gerdtham U-G. The impact of aging of health care expenditure in Sweden. Health Policy 1993; 24: 1-8
11. Anell A. Swedish healthcare under pressure. Health Econ 2005; 14:
12. Gudbjorrnsdottir S, Cederholm S, Nilsson PM, et al. Swedish National Diabetes Register, the national diabetes register in Sweden: an implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care. Diabetes Care 2003; 26 (4): 1270-6
13. The National Board of Health and Welfare (socialstyrelsen) [online]. Available from URL: http: //www.socialstyrelsen.se/Om-Sos/organisation/ Epidemiologiskt-Centrum/Enheter/CPK-PAR/NordDRG.htm [Accessed 2008 Nov 25]
14. Hsiao C. Analysis of panel data. 2nd ed. Cambridge: Cambridge University Press, 2003
15. Ballinger GA. Using generalized estimating equations for longitudinal data analysis. Organizational Research Methods 2004; 7 (2): 127-50
16. Basu A, Rathouz PJ. Estimating marginal and incremental effects on health outcomes using flexible link and variance function models. Biostatistics 2005; 6 (1): 93-109
17. Pharmaceutical Benefits Board (LFN) [online]. Available from URL: http://www.lfn.se [Accessed 2008 Nov 25]
18. Jönsson B, Cook JR, Pedersen TR. The cost-effectiveness of lipid lowering in patients with diabetes: results from the 4S trial. Diabetologia 1999; 42: 1293-301
19. Gudbjörnsdottir S, Cederholm, J, Adamsson, U. Nationella Diabetes Registret Årsrapport 2006. Rapport till socialstyrelsen 2006 [online]. Available from URL: http://www.nll.se/upload/IB/lg/hse/Kvalitet/Rapporter/ Arsrapport-NDR-2006.pdf [Accessed 2008 Nov 25]
20. Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in health and medicine. Oxford: Oxford University Press, 1996
21. Henriksson F, Jönsson B. Diabetes: the cost of illness in Sweden. J Int Med 1998; 244 (6): 461-8
22. Clarke P, Leal J, Kelman C, et al. Estimating the cost of complications of diabetes in Australia using administrative health-care data. Value Health 2008; 11 (2): 199-206.
23. National Diabetes Register [online]. Available from URL: https://www.ndr.nu/ [Accessed 2008 Nov 25]